![Xavier Matias-Guiu Guia](/media/upload/cache/129949_a115x115.jpg)
Xavier Matias-Guiu Guia
Degree: PhD
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Groups
Publications
-
Moreno-Bueno, G; Sanchez-Estevez, C; Cassia, R; Rodriguez-Perales, S; Diaz-Uriarte, R; Dominguez, O; Hardisson, D; Andujar, M; Prat, J; Matias-Guiu, X; Cigudosa, JC; Palacios, J
Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas
CANCER RESEARCH 63 5697-5702. .
-
Alvarez-Nunez, F; Mora, J; Matias-Guiu, X; Grp Estudio Marcadores Tumorales
Thyroid carcinomas of the follicular epithelium: tumor markers and oncogenes
MEDICINA CLINICA 121 264-269. .
-
Moreno-Bueno, G; Rodriguez-Perales, S; Sanchez-Estevez, C; Hardisson, D; Sarrio, D; Prat, J; Cigudosa, JC; Matias-Guiu, X; Palacios, J
Cyclin D1 gene (CCND1) mutations in endometrial cancer
ONCOGENE 22 6115-6118. .
-
Bellido, M; Aventin, A; Lasa, A; Estivill, C; Carnicer, MJ; Pons, C; Matias-Guiu, X; Bordes, R; Baiget, M; Sierra, J; Nomdedeu, JF
Id4 is deregulated by a t(6;14)(p22;q32) chromosomal translocation in a B-cell lineage acute lymphoblastic leukemia
HAEMATOLOGICA 88 994-1001. .
-
Ota, S; Catasus, L; Matias-Guiu, X; Bussaglia, E; Lagarda, H; Pons, C; Munoz, J; Kamura, T; Prat, J
Molecular pathology of atypical polypoid adenomyoma of the uterus
HUMAN PATHOLOGY 34 784-788. .
-
Moreno-Bueno, G; Hardisson, D; Sarrio, D; Sanchez, C; Cassia, R; Prat, J; Herman, JG; Esteller, M; Matias-Guiu, X; Palacios, L
Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120(ctn)) expression in endometrial cancer and endometrial atypical hyperplasia
JOURNAL OF PATHOLOGY 199 471-478. .
-
Matias-Guiu, X; Prat, J
Bifunctional pathway of uterine carcinosarcomas - Reply
HUMAN PATHOLOGY 34 300-300. .
-
Madas-Guiu, X; Catasus, L; Lagarda, H; Palomar, V; Quer, M
Germ-line mutations in the SDHD gene in patients with familial paraganglioma
Modern Pathology 16 478-478. .
-
Lloreta, J; Domingo, P; Pujol, RM; Arroyo, JA; Baixeras, N; Matias-Guiu, X; Gilaberte, M; Sambeat, MA; Serrano, S
Ultrastructural features of highly active antiretroviral therapy-associated partial lipodystrophy
VIRCHOWS ARCHIV 441 599-604. .
-
Moreno-Bueno, G; Hardisson, D; Sanchez, C; Sarrio, D; Cassia, R; Garcia-Rostan, G; Prat, J; Guo, MZ; Herman, JG; Matias-Guiu, X; Esteller, M; Palacios, J
Abnormalities of the aPC/beta-catenin pathway in endometrial cancer
ONCOGENE 21 7981-7990. .
-
Machin, P; Catasus, L; Pons, C; Munoz, J; Conde-Zurita, JM; Balmana, J; Barnadas, M; Marti, RM; Prat, J; Matias-Guiu, X
Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome.
JOURNAL OF CUTANEOUS PATHOLOGY 29 415-420. .
-
Matias-Guiu, X; Lagarda, H; Catasus, L; Bussaglia, E; Gallardo, A; Gras, E; Prat, J
Clonality analysis in synchronous or metachronous tumors of the female genital tract
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 21 205-211. .
Projects
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU